PHIO
Phio Pharmaceuticals Corp
NASDAQ: PHIO · HEALTHCARE · BIOTECHNOLOGY
$1.22
+3.39% today
Updated 2026-04-30
Market cap
$13.94M
P/E ratio
—
P/S ratio
48.01x
EPS (TTM)
$-1.45
Dividend yield
—
52W range
$1 – $3
Volume
0.3M
Phio Pharmaceuticals Corp (PHIO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $97000.00 | $399000.00 | $71000.00 | $34000.00 | $19000.00 | $15000.00 | $138000.00 | $21000.00 | $4362.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | +311.3% | -82.2% | -52.1% | -44.1% | -21.1% | +820.0% | -84.8% | -79.2% | -100.0% | — | — | — | — |
| Cost of revenue | — | $12.97M | $17.65M | $5.68M | $6.92M | $5.42M | $5.37M | $4.33M | $4.30M | $3.72M | $192000.00 | $193000.00 | $6.33M | $3.64M | $3000.00 |
| Gross profit | — | $-12.88M | $-17.25M | $-5.61M | $-6.89M | $-5.40M | $-5.36M | $138000.00 | $21000.00 | $-3.72M | $-192000.00 | $-193000.00 | $-6.33M | $-3.64M | $-3000.00 |
| Gross margin | — | -13276.3% | -4323.8% | -7900.0% | -20267.6% | -28400.0% | -35700.0% | 100.0% | 100.0% | -85190.3% | — | — | — | — | — |
| R&D | $6.62M | $10.45M | $17.65M | $5.68M | $6.92M | $5.42M | $5.37M | $4.33M | $4.30M | $3.72M | $8.89M | $7.01M | $6.33M | $3.64M | $4.62M |
| SG&A | — | $2.62M | $3.70M | $3.22M | $3.35M | $3.62M | $4.01M | $3.18M | $4.71M | $5.08M | $4.63M | $4.45M | $4.29M | $3.74M | $4.60M |
| Operating income | $-12.77M | $-12.97M | $-20.95M | $-8.83M | $-10.24M | $-9.02M | $-14.06M | $-7.36M | $-8.99M | $-8.79M | $-13.51M | $-11.46M | $-10.82M | $-7.39M | $-9.22M |
| Operating margin | — | -13376.3% | -5250.4% | -12431.0% | -30108.8% | -47447.4% | -93746.7% | -5336.2% | -42795.2% | -201581.8% | — | — | — | — | — |
| EBITDA | $-15.16M | $-12.70M | $-20.85M | $-8.74M | $-10.16M | $-8.96M | $-14.00M | $-7.28M | $-8.92M | $-8.72M | $-13.44M | $-11.27M | $-10.64M | $-7.38M | $-9.22M |
| EBITDA margin | — | -13095.9% | -5225.6% | -12308.5% | -29882.4% | -47168.4% | -93353.3% | -5277.5% | -42476.2% | -199931.2% | — | — | — | — | — |
| EBIT | $-15.32M | $-12.85M | $-20.95M | $-8.83M | $-10.24M | $-9.02M | $-14.07M | $-7.36M | $-8.99M | $-8.79M | $-13.51M | $-11.46M | $-10.83M | $-7.39M | $-9.22M |
| Interest expense | $0.00 | $30000.00 | $24000.00 | $0.00 | $0.00 | $0.00 | $1000.00 | $0.00 | $0.00 | $0.00 | $9000.00 | $175000.00 | — | $231000.00 | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-10.22M | $-12.88M | $-20.93M | $-8.80M | $-10.22M | $-8.99M | $-12.45M | $-7.36M | $-8.84M | $-8.79M | $-13.21M | $-11.30M | $-10.83M | $-7.15M | $-8.70M |
| Net income growth (YoY) | — | -26.0% | -62.5% | +57.9% | -16.2% | +12.0% | -38.4% | +40.9% | -20.1% | +0.5% | -50.2% | +14.4% | +4.2% | +34.0% | -21.7% |
| Profit margin | — | -13278.4% | -5244.4% | -12394.4% | -30067.6% | -47336.8% | -83013.3% | -5333.3% | -42100.0% | -201604.8% | — | — | — | — | — |